Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Archives of neurology - 1 Nov 2009

Hayden Kathleen M, Zandi Peter P, West Nancy A, Tschanz Joann T, Norton Maria C, Corcoran Chris, Breitner John C S, Welsh-Bohmer Kathleen A

Abstract excerpt

OBJECTIVE: To evaluate the influences of a family history of Alzheimer dementia (FHxAD) and the apolipoprotein E epsilon4 genotype (APOE epsilon4) on cognitive decline. DESIGN, SETTING, AND PARTICIPANTS: Residents of Cache County, Utah, aged 65 years or older, were invited to participate. At base...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Neuropsychological Tests

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 19901170
DOI: 10.1001/archneurol.2009.237
PMCID: PMC2900192

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19901170-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.PMID 19901170Read ↗

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.Semantic proximity Read ↗

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.Semantic proximity Read ↗

A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.Semantic proximity Read ↗

Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.Semantic proximity Read ↗

Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.Semantic proximity Read ↗

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.Semantic proximity Read ↗

Apolipoprotein E genotype and mortality: findings from the Cache County Study.Semantic proximity Read ↗

APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.Semantic proximity Read ↗

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older populationSemantic proximity Read ↗

Apolipoprotein E moderates the association between Non-<i>APOE</i>Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive FunctionSemantic proximity Read ↗

Neuropathology-Independent Association Between APOE Genotype and Cognitive Decline Rate in the Normal Aging-Early Alzheimer ContinuumSemantic proximity Read ↗

Effect of APOE and CD33 on Cognitive Decline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.